DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,252,864 | -28.2% | 25,203 | -30.6% | 0.15% | +0.7% |
| Q2 2023 | $8,712,720 | -28.9% | 36,303 | -25.4% | 0.15% | -39.4% |
| Q1 2023 | $12,259,982 | -3.2% | 48,643 | +2.0% | 0.24% | -11.7% |
| Q4 2022 | $12,661,861 | -12.1% | 47,705 | -14.5% | 0.27% | -6.8% |
| Q3 2022 | $14,403,000 | +20.2% | 55,763 | +18.0% | 0.29% | +25.2% |
| Q2 2022 | $11,978,000 | -38.8% | 47,245 | -29.2% | 0.23% | -10.3% |
| Q1 2022 | $19,587,000 | -15.8% | 66,776 | -5.6% | 0.26% | -10.9% |
| Q4 2021 | $23,262,000 | +9.1% | 70,703 | +1.0% | 0.29% | -1.0% |
| Q3 2021 | $21,318,000 | +6.3% | 70,023 | -6.3% | 0.30% | +2.1% |
| Q2 2021 | $20,052,000 | +18.9% | 74,722 | -0.3% | 0.29% | +25.0% |
| Q1 2021 | $16,864,000 | +2.7% | 74,923 | +1.3% | 0.23% | -0.9% |
| Q4 2020 | $16,426,000 | +1.5% | 73,944 | -1.6% | 0.23% | -8.6% |
| Q3 2020 | $16,185,000 | +23.2% | 75,164 | +1.1% | 0.26% | +14.3% |
| Q2 2020 | $13,141,000 | +25.4% | 74,313 | -1.8% | 0.22% | +9.3% |
| Q1 2020 | $10,477,000 | -45.6% | 75,696 | -39.7% | 0.20% | -18.7% |
| Q4 2019 | $19,273,000 | +20.3% | 125,577 | +13.2% | 0.25% | +11.5% |
| Q3 2019 | $16,020,000 | -14.8% | 110,922 | -15.7% | 0.23% | -21.8% |
| Q2 2019 | $18,811,000 | -5.7% | 131,617 | -12.9% | 0.29% | +13.8% |
| Q1 2019 | $19,950,000 | +34.2% | 151,114 | +4.8% | 0.25% | +22.1% |
| Q4 2018 | $14,869,000 | +24.1% | 144,191 | +30.8% | 0.21% | +28.4% |
| Q3 2018 | $11,982,000 | +20.5% | 110,271 | +9.4% | 0.16% | +9.5% |
| Q2 2018 | $9,944,000 | -36.1% | 100,767 | -36.6% | 0.15% | -43.1% |
| Q1 2018 | $15,562,000 | +10.7% | 158,940 | +4.9% | 0.26% | +5.7% |
| Q4 2017 | $14,060,000 | +10.7% | 151,475 | +2.3% | 0.25% | 0.0% |
| Q3 2017 | $12,698,000 | +38.3% | 148,030 | +36.0% | 0.25% | +30.2% |
| Q2 2017 | $9,183,000 | +1.4% | 108,813 | +2.8% | 0.19% | -3.1% |
| Q1 2017 | $9,057,000 | +71.6% | 105,893 | +56.1% | 0.20% | +58.5% |
| Q4 2016 | $5,279,000 | +6.5% | 67,825 | +7.3% | 0.12% | +3.4% |
| Q3 2016 | $4,955,000 | -20.6% | 63,205 | +2.3% | 0.12% | -21.7% |
| Q2 2016 | $6,237,000 | +8.1% | 61,756 | +1.6% | 0.15% | +8.6% |
| Q1 2016 | $5,768,000 | +123.0% | 60,807 | +118.3% | 0.14% | +112.1% |
| Q4 2015 | $2,587,000 | -10.8% | 27,854 | -18.1% | 0.07% | -13.2% |
| Q3 2015 | $2,899,000 | -2.8% | 34,020 | -2.4% | 0.08% | 0.0% |
| Q2 2015 | $2,984,000 | -3.5% | 34,862 | -4.2% | 0.08% | +1.3% |
| Q1 2015 | $3,091,000 | +0.1% | 36,403 | +1.1% | 0.08% | 0.0% |
| Q4 2014 | $3,087,000 | +66.0% | 36,022 | +47.2% | 0.08% | +41.5% |
| Q3 2014 | $1,860,000 | +5.3% | 24,475 | +9.0% | 0.05% | +1.9% |
| Q2 2014 | $1,767,000 | -5.2% | 22,449 | -9.7% | 0.05% | -1.9% |
| Q1 2014 | $1,864,000 | +7.8% | 24,857 | +11.0% | 0.05% | +12.8% |
| Q4 2013 | $1,729,000 | +11.0% | 22,397 | -0.3% | 0.05% | +4.4% |
| Q3 2013 | $1,557,000 | +22.0% | 22,467 | +11.5% | 0.04% | +15.4% |
| Q2 2013 | $1,276,000 | – | 20,152 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |